Competitiveness bargaining in France: a study of multiple union action in the automotive industry

Competitiveness agreements in France became a much discussed feature of company-level responses to the 2008 crisis and aftermath. Such innovations raise several issues in a context of multi-unionism, in terms of how different workplace unions of varying organisational cultures respond, but also the consequences for inter-union relations. It is observed that such dynamics are complicated by the representative reforms of 2008 which link local bargaining power to performance in workplace elections. Based on case study analysis of the crisis-ridden automotive industry, this article therefore examines how union responses to competitiveness bargaining are proceeding in light of the revised representative rules

Competitiveness bargaining in France: a study of multiple union action in the automotive industry

Competitiveness agreements in France became a much discussed feature of company-level responses to the 2008 crisis and aftermath. Such innovations raise several issues in a context of multi-unionism, in terms of how different workplace unions of varying organisational cultures respond, but also the consequences for inter-union relations. It is observed that such dynamics are complicated by the representative reforms of 2008 which link local bargaining power to performance in workplace elections. Based on case study analysis of the crisis-ridden automotive industry, this article therefore examines how union responses to competitiveness bargaining are proceeding in light of the revised representative rules

Increased hypolipidemic benefits of cis-9, trans-11 conjugated linoleic acid in combination with trans-11 vaccenic acid in a rodent model of the metabolic syndrome, the JCR:LA-cp rat

<p>Abstract</p> <p>Background</p> <p>Conjugated linoleic acid (<it>cis</it>-9, <it>trans</it>-11 CLA) and <it>trans</it>-11 vaccenic acid (VA) are found naturally in ruminant-derived foods. CLA has been shown to have numerous potential health related effects and has been extensively investigated. More recently, we have shown that VA has lipid-lowering properties associated with reduced hepatic lipidogenesis and chylomicron secretion in the JCR:LA<it>-cp </it>rat. The aim of this study was to evaluate potential additional hypolipidemic effects of purified forms of CLA and VA in an animal model of the metabolic syndrome (the JCR:LA-<it>cp </it>rat).</p> <p>Methods</p> <p>Twenty four obese JCR:LA-<it>cp </it>rats were randomized and assigned to one of three nutritionally adequate iso-caloric diets containing 1% w/w cholesterol and 15% w/w fat for 16 wk: 1) control diet (CD), 2) 1.0% w/w <it>cis</it>-9, <it>trans</it>-11 CLA (CLA), 3) 1.0% w/w VA and 1% w/w <it>cis</it>-9, <it>trans</it>-11 CLA (VA+CLA). Lean rats were fed the CD to represent normolipidemic conditions.</p> <p>Results</p> <p>Fasting plasma triglyceride (TG), total cholesterol and LDL-cholesterol concentrations were reduced in obese rats fed either the CLA diet or the VA+CLA diet as compared to the obese control group (p < 0.05, p < 0.001; p < 0.001, p < 0.01; p < 0.01, p < 0.001, respectively). The VA+CLA diet reduced plasma TG and LDL-cholesterol to the level of the normolipidemic lean rats and further decreased nonesterified fatty acids compared to the CLA diet alone. Interestingly, rats fed the VA+CLA diet had a higher food intake but lower body weight than the CLA fed group (P < 0.05). Liver weight and TG content were lower in rats fed either CLA (p < 0.05) or VA+CLA diets (p < 0.001) compared to obese control, consistent with a decreased relative protein abundance of hepatic acetyl-CoA carboxylase in both treatment groups (P < 0.01). The activity of citrate synthase was increased in liver and adipose tissue of rats fed, CLA and VA+CLA diets (p < 0.001) compared to obese control, suggesting increased mitochondrial fatty acid oxidative capacity.</p> <p>Conclusion</p> <p>We demonstrate that the hypolipidemic effects of chronic <it>cis</it>-9, <it>trans</it>-11 CLA supplementation on circulating dyslipidemia and hepatic steatosis are enhanced by the addition of VA in the JCR:LA-<it>cp </it>rat.</p

Vaccenic and Elaidic Acid Modify Plasma and Splenocyte Membrane Phospholipids and Mitogen-Stimulated Cytokine Production in Obese Insulin Resistant JCR: LA-cp Rats

This study assessed the long-term effects of dietary vaccenic acid (VA) and elaidic acid (EA) on plasma and splenocyte phospholipid (PL) composition and related changes in inflammation and splenocyte phenotypes and cytokine responses in obese/insulin resistant JCR:LA-cp rats. Relative to lean control (Ctl), obese Ctl rats had higher serum haptoglobin and impaired T-cell-stimulated cytokine responses. VA and EA diets improved T-cell-stimulated cytokine production; but, only VA normalized serum haptoglobin. However, EA- and VA-fed rats had enhanced LPS-stimulated cytokine responses. The changes elicited by VA were likely due changes in essential fatty acid composition in PL; whereas EA-induced changes may due to direct incorporation into membrane PL

Inter-union solidarity and strategic group identity: insights from works councils in the French car industry

No abstract available